Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
New Kit offers BioXp automation workflow from candidate sequence to amplified DNA in daysSAN DIEGO, Nov. 03, 2023 -- Telesis Bio Inc. , a leader in automated multi-omic and synthetic biology...
Source: marketscreener.com